Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (341-350 of 1,211) with videos related to

Pageof 122
Sort By:
Circulation|August 29, 2007
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failureScott D Solomon, Joanna Dobson, Stuart Pocock, et al.
Circulation. Heart Failure|October 19, 2014
Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fractionAkshay S Desai, Brian Claggett, Marc A Pfeffer, et al.
European Heart Journal|January 29, 2016
Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patientsElke Platz, Eldrin F Lewis, Hajime Uno, et al.
European Journal of Heart Failure|September 26, 2022
Health-related quality of life in acute heart failure: association between patient-reported symptoms and markers of congestionMatthew M Y Lee, Ross T Campbell, Brian L Claggett, et al.
Journal of the American Heart Association|June 24, 2020
Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC StudyDavid Aguilar, Caroline Sun, Ron C Hoogeveen, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 9, 2023
Firibastat Versus Ramipril After Acute Mechanical Reperfusion of Anterior Myocardial Infarction: A Phase 2 StudyGilles Montalescot, John H Alexander, Angel Cequier-Fillat, et al.
JAMA Cardiology|September 30, 2024
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF TrialSanjiv J Shah, Marzia Rigolli, Atefeh Javidialsaadi, et al.
JAMA Cardiology|May 22, 2023
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the USSenthil Selvaraj, Brian L Claggett, C Cristina Quarta, et al.
Journal of the American College of Cardiology|May 30, 2020
Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 PandemicAnkeet S Bhatt, Alea Moscone, Erin E McElrath, et al.
Circulation|June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)Sheila M Hegde, Brian Claggett, Amil M Shah, et al.
Pageof 122

Showing results (341-350 of 1,211) with videos related to

Sort By:
Pageof 122
Circulation|August 29, 2007
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failureScott D Solomon, Joanna Dobson, Stuart Pocock, et al.
Circulation. Heart Failure|October 19, 2014
Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fractionAkshay S Desai, Brian Claggett, Marc A Pfeffer, et al.
European Heart Journal|January 29, 2016
Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patientsElke Platz, Eldrin F Lewis, Hajime Uno, et al.
European Journal of Heart Failure|September 26, 2022
Health-related quality of life in acute heart failure: association between patient-reported symptoms and markers of congestionMatthew M Y Lee, Ross T Campbell, Brian L Claggett, et al.
Journal of the American Heart Association|June 24, 2020
Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC StudyDavid Aguilar, Caroline Sun, Ron C Hoogeveen, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 9, 2023
Firibastat Versus Ramipril After Acute Mechanical Reperfusion of Anterior Myocardial Infarction: A Phase 2 StudyGilles Montalescot, John H Alexander, Angel Cequier-Fillat, et al.
JAMA Cardiology|September 30, 2024
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF TrialSanjiv J Shah, Marzia Rigolli, Atefeh Javidialsaadi, et al.
JAMA Cardiology|May 22, 2023
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the USSenthil Selvaraj, Brian L Claggett, C Cristina Quarta, et al.
Journal of the American College of Cardiology|May 30, 2020
Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 PandemicAnkeet S Bhatt, Alea Moscone, Erin E McElrath, et al.
Circulation|June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)Sheila M Hegde, Brian Claggett, Amil M Shah, et al.
Pageof 122